RecruitingNot ApplicableNCT07205120

Fluid Guided Heart Failure Treatment at the Cleveland Clinic

Fluid Guided Heart Failure Treatment


Sponsor

Bodyport Inc.

Enrollment

50 participants

Start Date

Oct 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

FIGHT-HF is an exploratory non-randomized open-label study evaluating a heart failure management intervention. The goal of this pilot is to assess the performance of a fluid-guided heart failure management program and Alert Response Guide (ARG) using the Bodyport Cardiac Scale and Congestion Index in 50 adult participants with acute and chronic heart failure, who are followed by a Cleveland Clinic cardiologist.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a guided fluid management approach for people hospitalized with worsening heart failure. By tracking fluid levels carefully and using that information to direct treatment, the team hopes to help patients recover more quickly and avoid future hospitalizations. **You may be eligible if...** - You are 21 or older - You have been admitted to the Cleveland Clinic for a flare-up (decompensation) of heart failure - You can speak and read English **You may NOT be eligible if...** - Your heart failure symptoms are the most severe (Class IV — symptoms at rest) - You have received or are planning to receive a heart transplant or a ventricular assist device within the next year - Your kidneys are functioning very poorly (GFR below 25) and not responding to water pills (diuretics), or you are on dialysis - You regularly receive IV heart failure treatments at home (such as IV diuretics or IV heart-supporting drugs) - Your life expectancy is less than 12 months - You are pregnant or plan to become pregnant in the next year - You weigh over 375 pounds - You cannot stand on two bare feet without assistance Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHeart Failure Management Intervention

Participants will receive access to their weight and fluid levels on the Cardiac Scale and through the Bodyport Patient Portal. The provider will receive access to the Congestion Index, alerts, and Clinical Dashboard to support the remote management of the participant. The provider will receive a notice when an alert is generated and twice weekly reminders until the Congestion Index returns below an alert threshold. When an alert is generated, providers will attempt to contact the participant and will be encouraged to follow the recommendations contained within the ARG. Providers will also be encouraged to provide feedback and suggest improvements to the ARG throughout the study. Any changes to medical therapy resulting from an alert will be documented in the Bodyport Clinical Dashboard.


Locations(1)

The Cleveland Clinic

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07205120


Related Trials